Suppr超能文献

通过分子对接和分子动力学分析对药用植物“ ”的植物成分抗新型冠状病毒2进行计算机模拟研究。 (注:原文中“Medicinal Herb ''”部分缺失具体植物名称)

In Silico Investigation of Phytoconstituents of Medicinal Herb '' Against SARS-CoV-2 by Molecular Docking and Molecular Dynamics Analysis.

作者信息

Lakhera Shradha, Devlal Kamal, Ghosh Arabinda, Rana Meenakshi

机构信息

Department of Physics, School of Sciences, Uttarakhand Open University, Haldwani, 263139, Uttarakhand, India.

Microbiology Division, Department of Botany, Guwahati University, Guwahati, 781014, Assam, India.

出版信息

Results Chem. 2021 Sep 24:100199. doi: 10.1016/j.rechem.2021.100199.

Abstract

Unavailability of treatment for the SARS-CoV-2 virus has raised concern among the population worldwide. This has led to many attempts to find alternative options to prevent the infection of the disease, including focusing on vaccines and drugs. The use of natural products and herbal extracts can be a better option in beating the virus and boosting up immunity. In the present paper, we have done a systematic study of papain-like protease of COVID-19 virus with the chemical constituents of herbal plant . Screening of the pharmacokinetic properties is done with thirty-two phytoconstituents of which help us in selecting the most active components of the plant. After selection molecular docking is performed with Aristololactam (CHNO), Fargesin (CHO), l-asarinin (CHO), Lignans Machilin F (CHO), Piperundecalidine (CHNO), and Pluviatilol (CHO). Molecular dynamic (MD) is also performed with the inhibitor-receptor complex which suggest significant inhibition and a stable complex of I-Asarinin with PL. Docking scores and simulation results suggest that I-Asarinin can act as a potential drug like candidate against COVID-19.

摘要

无法获得针对SARS-CoV-2病毒的治疗方法引发了全球民众的担忧。这导致人们多次尝试寻找预防该疾病感染的替代方案,包括专注于疫苗和药物。使用天然产物和草药提取物可能是战胜病毒和增强免疫力的更好选择。在本文中,我们对新冠病毒的木瓜样蛋白酶与草药植物的化学成分进行了系统研究。对32种植物成分进行了药代动力学特性筛选,这有助于我们选择该植物中最具活性的成分。选择后,用马兜铃内酰胺(CHNO)、法尔格辛(CHO)、l-细辛脂素(CHO)、木脂素马兜铃F(CHO)、胡椒十一肽(CHNO)和普卢维蒂洛尔(CHO)进行分子对接。还对抑制剂-受体复合物进行了分子动力学(MD)研究,结果表明I-细辛脂素对木瓜样蛋白酶有显著抑制作用且二者形成稳定复合物。对接分数和模拟结果表明,I-细辛脂素可作为一种潜在的抗新冠病毒候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aa0/8478074/22ce7441213a/ga1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验